Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study.

Salemyr J, Bang P, Örtqvist E.

Pediatr Diabetes. 2011 Aug;12(5):501-5. doi: 10.1111/j.1399-5448.2010.00723.x.

PMID:
21443584
2.

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis.

Monami M, Marchionni N, Mannucci E.

Diabetes Obes Metab. 2009 Apr;11(4):372-8. doi: 10.1111/j.1463-1326.2008.00976.x. Review.

PMID:
19267715
3.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
4.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

5.

Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons.

Sanches AC, Correr CJ, Venson R, Pontarolo R.

Diabetes Res Clin Pract. 2011 Dec;94(3):333-9. doi: 10.1016/j.diabres.2011.09.001. Review.

PMID:
21992870
6.

Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

McKeage K, Goa KL.

Treat Endocrinol. 2002;1(1):55-8. Review.

PMID:
15765621
7.

Dosing of insulin glargine in the treatment of type 2 diabetes.

Barnett A.

Clin Ther. 2007 Jun;29(6):987-99. Review.

PMID:
17692716
8.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
9.

Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.

Mathiesen ER, Damm P, Jovanovic L, McCance DR, Thyregod C, Jensen AB, Hod M.

Diabetes Metab Res Rev. 2011 Sep;27(6):543-51. doi: 10.1002/dmrr.1213. Review.

PMID:
21557440
10.

Insulin treatment in type 1 diabetes.

Bolli GB.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:105-9. Review.

PMID:
16627392
11.

Insulin glargine in a Brazilian state: should the government disinvest? An assessment based on a systematic review.

Caires de Souza AL, de Assis Acurcio F, Guerra Júnior AA, Rezende Macedo do Nascimento RC, Godman B, Diniz LM.

Appl Health Econ Health Policy. 2014 Feb;12(1):19-32. doi: 10.1007/s40258-013-0073-6. Review.

PMID:
24385261
12.

Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?

Monnier L, Colette C, Owens D.

Diabetes Metab. 2013 Dec;39(6):468-76. doi: 10.1016/j.diabet.2013.09.003. Review.

13.

Newer basal insulin analogues: degludec, detemir, glargine.

Kalra S.

J Pak Med Assoc. 2013 Nov;63(11):1442-4. Review. No abstract available.

Supplemental Content

Support Center